ODB Bio Investors Meeting, organized by Rabanales 21 and Canaan Research on last 24th November, included in their Expert Committee to Canvax Biotech, and also to Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC) and Instituto Municipal de Desarrollo Económico y Empleo de Córdoba (IMDEEC). On the other hand, there were some Investment funds such […]
Learn More
New job offer: Scientist highly trained in animal models of disease Canvax Biotech is a spanish based Drug Discovery company located in the Technological Park Rabanales 21 in Córdoba. Canvax aims at bringing novel therapeutics for untreatable disorders mostly focused on Oncology and Autoimmune diseases. Job description Canvax is seeking an experienced researcher highly […]
Learn More
This news, which has been highlighted by more than one hundred national newspapers, has been explained that a trained dog is able to detect whether a person has cancer sickness even before medical tests could determine it. So is how Canvax hast got olfactory proteins with the aim of being able to get a better […]
Learn More
Elier Paz, CEO of Canvax Biotech, has participated the last Wednesday 29th of June, in the Business Forum ‘Commitment with Córdoba «, organized by the Business Confederation of Córdoba (CECO), in collaboration with Cajasol Foundation. As representative of the Health Industry of the city, Elier Paz, was part of First panel of Lectureships. To […]
Learn More
Canvax has participated in the VII Conferences on Dissemination of Molecular and Cellular Biology, Genetics and Biotechnology Research at the University of Córdoba (UCO), with an interesting presentation based on Canvax´s main advances in Drug Discovery & Diagnostics. More than 200 people, mostly students of scientific disciplines, have postponed their holidays to participate in those […]
Learn More
Canvax Biotech, has received today the visit of the Minister of Employment and Social Security in functions, Fatima Báñez, who taking advantage of its presence in Cordoba, visited today Canvax Biotech´s laboratories to discover at first hand its important researcher labour of the prestigious biotech company and the progress in Cancer diagnosis and development of […]
Learn More
FRIDASTEM platform has been established with the aim to accelerate small molecule drug discovery against specific kinases and GPCRs involved in Cancer Stem Cells (CSC) proliferation, migration, invasion or metastasis. CSC are believed to be the cause of resistance to current cancer therapies. The drug discovery of drugs targeting this population of cells within a tumoris therefore of […]
Learn More
Last 5th April took place at Hotel Hilton Garden Hill Milan North (Italy) the Annual Sales Meeting of Voden Medical Life Sciences Division, new distributor of Canvax in Italy. During the meeting, Jesús C. Morales, Business Development Manager and Luis A. Torres, Production Manager, had the opportunity to introduce to Voden´s 25 sales specialists Canvax´s […]
Learn More
Canvax has recently obtained the Innovative SME distinction granted by Spain’s Economy and Competitiveness Ministry that awards to highly innovative activity level SMEs according to ECC/1087/2015. This is a distinction that strengthensCanvax as one of the most innovative companies in Spain, becoming part of a select group of enterprises. The Innovative SME stamp rewards the […]
Learn More
In today´s edition, Diario Córdoba publishes an interview with Elier Paz, CEO of Canvax Biotech. During the interview, the journalist Irina Marzo asked about most updated information about the company, currents projects inside Drug discovery and lead molecules. For more information, read the full new here.
Learn More